-transparent.png){kind=logo}
Three MAb M2, B6, P1 (IgG1 type) against human urinary trypsin inhibitor (UTI), a glycoprotein with antiinflammatory properties, have been produced by hybridization of mouse myeloma cells P3o1 with spleen cells of immunized mice BALB/c. Competitive ELISA-examination of peroxidase conjugates of M2, B6, and P1 MAb in the presence of the trypsin binding domain shows the highest affinity of M2 antibody for this domain. On the basis of MAb M2 competitive ELISA of UTI concentration in urine is proposed. ELISA detectable changes in the UTI content of urine from patients with nephritis without renal failure can be considered as an early index of renal parenchyma damage.
Related Publications
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
March 1994,
Bioorganicheskaia khimiia,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
November 1989,
Experimental cell research,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
November 1994,
Molecular and cellular endocrinology,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
July 2007,
Journal of immunological methods,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
June 1992,
European journal of immunology,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
December 1999,
Nihon rinsho. Japanese journal of clinical medicine,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
July 2010,
Nihon rinsho. Japanese journal of clinical medicine,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
August 2005,
Nihon rinsho. Japanese journal of clinical medicine,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
April 1982,
Proceedings of the National Academy of Sciences of the United States of America,
O Ogloblina, and
R Beckert, and
L Belova, and
M Bauer, and
M Smirnov
October 1996,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
